| Schedule of Discontinued Operations |
Schedule of Discontinued Operations
Summarized
balance sheet information of assets and liabilities held for sale is below:
| | |
June 30, | | |
December 31, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| Cash and cash equivalents | |
$ | 576,806 | | |
$ | 5,025,600 | |
| Prepaid expenses and other current assets | |
| 124,191 | | |
| 155,935 | |
| Current assets held for sale | |
| 700,997 | | |
| 5,181,535 | |
| Total assets held for sale | |
$ | 700,997 | | |
$ | 5,181,535 | |
| | |
| | | |
| | |
| Accounts payable | |
$ | 235,566 | | |
$ | 569,073 | |
| Accrued expenses | |
| 490,473 | | |
| 1,689,630 | |
| Total current liabilities held for sale | |
| 726,039 | | |
| 2,258,703 | |
| Total liabilities held for sale | |
$ | 726,039 | | |
$ | 2,258,703 | |
The
statement of operations of discontinued operations are summarized below:
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
For the Three Months Ended June 30, | | |
For the Six Months Ended June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
| | |
| | |
| | |
| |
| Research and development | |
| 411,767 | | |
| 422,566 | | |
| 679,590 | | |
| 925,187 | |
| General and administrative | |
| 888,978 | | |
| - | | |
| 2,268,285 | | |
| - | |
| Total operating expenses | |
| 1,300,745 | | |
| 422,566 | | |
| 2,947,875 | | |
| 925,187 | |
| Net loss from discontinued operations | |
| (1,300,745 | ) | |
| (422,566 | ) | |
| (2,947,875 | ) | |
| (925,187 | ) |
|